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Objective: To examine the patterns and predictors of inter-pregnancy body mass index (BMI) 
change and its impact on perinatal outcomes in the second pregnancy. 
Design: Retrospective cohort study 
Setting: Tertiary teaching hospital in Adelaide, Australia 
Population: Women with their first and second consecutive, singleton deliveries occurring 
between 2000 and 2012 (N= 5,371). 
Methods: Inter-pregnancy weight change calculated based on difference between BMI at 
respective antenatal booking visits. Association between inter-pregnancy weight change and 
perinatal outcomes investigated using multivariate generalised linear models, with stratification 
according to initial maternal BMI category in first pregnancy. 
Main outcome measures: Gestational diabetes (GDM); pregnancy induced hypertensive 
disorders; small-for-gestational age (SGA); preterm birth; large-for-gestational age (LGA) and 
macrosomia (>4,500g). 
Results: On average, women with a normal BMI gained 1kg/m2 between first and second 
pregnancies, while women who were overweight or obese gained 1.37kg/m2. Among women with 
a normal BMI in their first pregnancy, a BMI increase of ≥4kg/m2 was associated with increased risk 
of developing GDM (aRR 1.97; 95% CI 1.22-3.19), a macrosomic (aRR 4.06; 95% CI 2.25-7.34) or LGA 
infant (aRR 1.31 0.96-1.78) in the second pregnancy, while a reduction in BMI (≤-2kg/m2) was 
associated with an increased risk of SGA (aRR 1.94; 1.19-3.16). Among women who were 
overweight or obese in their first pregnancy, a BMI increase of ≥2 to 4 and ≥4 kg/m2 was associated 
with increased risks of developing GDM in the second pregnancy (aRR 1.39; 95%CI 1.01-1.91 and 
aRR 1.64 95%CI 1.16-2.31; ptrend <0.001), while no associations were observed for a BMI increase 
and risk of a macrosomic, SGA, or LGA infant. In contrast, reduction in BMI (≤-2kg/m2) was 
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associated with a reduced risk of GDM (aRR 0.58 95% CI 0.37-0.90) and SGA (aRR 0.47; 95%CI 0.25-
0.87).   
Conclusion: Increases in BMI between pregnancies is associated with an increased risk for 
perinatal complications, even in normal-weight women, while a reduction in BMI is associated 
with improved perinatal outcomes among women who are overweight/obese. Inter-pregnancy 
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Obesity is a growing problem worldwide with significant morbidity and public health 
consequences. In 2008, 56% of Australian women over 20 years old were overweight or obese 
[1] and 26.2% and 23.8% of pregnant South Australian women were overweight or obese at 
their 10 week booking visit, respectively [2].  
 
It is well established that entering pregnancy with a high BMI is associated with numerous 
complications, including hypertensive disorders of pregnancy, thromboembolic disorders, 
infection, caesarean section and stillbirth [2-10]. Furthermore, infants born to overweight and 
obese women are more likely to be macrosomic, diagnosed with a congenital anomaly or 
require neonatal intensive care [2-10].  
 
Villamor and Cnattingius demonstrated in 2006 that increasing weight gain between first and 
second pregnancies increased the likelihood of developing gestational diabetes (aOR 2.09 
(1.68-2.61) per >3 BMI unit increase) and preeclampsia (aOR 1.78 (1.52-2.08) per >3 BMI unit 
increase), in Swedish women of any initial BMI category. A sub analysis of women with a 
normal booking BMI <25kg/m2 demonstrated that the risk of adverse perinatal outcomes 
increased with significant weight gain, even if the weight gain did not cause the woman to 
become overweight[11], i.e. women who may have gained more than 3 BMI units but still 
remained within the normal weight category (<25kg/m2). 
 
Subsequently, multiple studies have investigated the effect of inter-pregnancy weight change 
on the risk of maternal and neonatal complications in Europe and the United States [12-19]. 
Previous findings have been inconsistent, but generally showed that inter-pregnancy weight 
gain in women of normal BMI in their first pregnancy was associated with adverse perinatal 
outcomes in the second pregnancy. To date, there are limited studies specifically examining 
the impact of BMI loss between pregnancies, which could be expected to have a protective 
effect on subsequent perinatal outcomes among women who are overweight or obese in their 
first pregnancy. Children born to women following anti-obesity surgery enjoy a significant 
reduction in severe obesity, insulin resistance and cardiometabolic markers, when compared 
to those born prior to maternal surgery, which is sustained into adolescence. This suggests 
that a benefit is most likely conferred, and suggests that these benefits may extend far beyond 
the neonatal period [20]. 
 
Therefore, the purpose of this study is to investigate patterns and predictors of weight change 
between pregnancies in a contemporary Australian cohort, and the impact of such changes 




We conducted a retrospective cohort study utilising routinely collected data on all births 
occurring in the Women’s and Children’s Health Network (WCHN) in South Australia, 
Australia. The project was approved by the Human Research Ethics Committees of the 
Women’s and Children’s Health Network and the University of Adelaide in South Australia (ID 
REC2219/10/14).  
 
All women who had their first two consecutive singleton births between January 2000 and 
December 2012 at the Women’s and Children’s Hospital (WCH) in Adelaide, South Australia 
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were included (N=8,368). Women were excluded if their BMI was not recorded during either 
pregnancy (N=2,596), and if their BMI was < 18.5 kg/m2 during their first pregnancy (N=218). 
Outliers were assessed and 183 women were excluded with a height difference of >5cm 
between pregnancies, leaving a final cohort of 5,371 women. Weight was not routinely 
recorded at time of delivery, and subsequently, the effect of gestational weight gain was not 
investigated. 
 
Outcomes were based on data routinely collected and recorded in the WCH Perinatal 
Statistics Collection. Data is collected on the pregnancy and outcome of every live birth and 
late fetal death occurring at the WCH. Data are collected according to the guidelines of the 
Pregnancy Outcome Unit of the South Australian Department of Health for the 
Supplementary Birth Records (SBRs) and in consultation with the senior clinicians at the 
hospital. Data collection began in the late 1980s and complete, validated data are available 
from 1990 onwards. Data are collected by a specially trained research midwife from the 
women’s medical records following delivery through use of a structured coding sheet. It is 
important to note that included in the medical record is the South Australian Pregnancy 
Record (SAPR), which is a hand-held antenatal record carried by each woman throughout her 
pregnancy and contains notes by all health providers consulted during the pregnancy. From 
the medical records, information is collected on maternal illnesses (e.g. diabetes, gestational 
diabetes, epilepsy, asthma and psychiatric illness), lifestyle factors (e.g. smoking), obstetric 
history, course of delivery, pregnancy complications and newborn characteristics (e.g. birth 
weight). Inter-pregnancy interval was calculated from delivery to conception. All SBRs are 
checked manually for completeness and data discrepancies and then go through a series of 
automated validation procedures during data entry. The information in the perinatal statistics 
collection has been previously validated and has been shown to be very reliable when 
compared with hospital medical records [21], and has been utilised in previous studies 
examining perinatal outcomes [22-24] 
 
Weight change was measured in terms of BMI units between the booking visit of the first and 
second pregnancy, women who had their first antenatal visit after 15 weeks gestation did not 
have a booking weight recorded. 
 
Baseline characteristics and determinants of inter-pregnancy weight gain were assessed. 
Outcomes included were gestational diabetes (diagnosis as marked on data collection sheet, 
OGTTs not); pregnancy induced hypertensive disorders (diagnosis as marked on data 
collection sheet: preeclampsia, gestational hypertension, chronic hypertension, 
superimposed preeclampsia) small-for-gestational age (SGA - <10th centile customised for 
maternal height, weight, fetal sex, gestation and ethnicity); large-for-gestational age (LGA - 
>10th centile customised for maternal height, weight, gestation and ethnicity), macrosomia 
>4500g, and preterm birth. 
 
Women were grouped according to the world health organisation (WHO) BMI classifications; 
normal weight 18.5-25 kg/m2, overweight 25-30 kg/m2 obese >30 kg/m2. We hypothesised 
that weight change might behave physiologically differently when occurring in a woman who 
was already overweight, with a possible different magnitude of effect on GDM, hypertensive 
disorders of pregnancy and birthweight, as she moves either closer to or further away from 
the healthy weight range. Thus, overweight and obese women were analysed separately to 
women of normal BMI.  
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Baseline characteristics and determinants of inter-pregnancy BMI change were assessed 
using a Kruskal-Wallis test. The impact of BMI change between pregnancies on subsequent 
perinatal outcomes in the second pregnancy were compared using a generalised linear model 
(Poisson distribution) with robust variance estimates, with resulting relative risks (RR) and 
95% confidence intervals (CIs). Inter-pregnancy BMI change was included as a categorical 
outcome and defined as ≤-2, >-2 to <2, ≥2 to <4, and ≥4 kg/m2, with a weight change of >-2 
to <2 used as the reference category. Analyses were stratified according to initial maternal 
BMI category in the first pregnancy (normal weight [BMI<25 kg/m2] or overweight/obese 
[BMI≥25 kg/m2]). Analyses were adjusted for maternal covariates including age, 
socioeconomic status, maternal BMI in first pregnancy, smoking status, race, pregnancy 
interval time, and perinatal outcomes in the first pregnancy including gestational diabetes, 
pregnancy induced hypertensive disorders, birth method, and appropriateness of fetal 
growth (i.e. LGA or SGA). We also estimated incidence of each outcome during the second 
pregnancy by categories of change in BMI from the ﬁrst pregnancy, and tested the linearity 
of the associations using the Cochran-Armitage test. A linear trend was also investigated in 
the multivariate generalised linear model using the Wald test for change in BMI when the 
ordinal variable was introduced into the logistic regression model as a continuous predictor. 
The potential interaction between baseline BMI category in the first pregnancy and 
interpregnancy BMI change was investigated by including an interaction term in the 
multivariate generalised linear model. Statistical analyses were performed using Stata 11.1 




Among the total eligible cohort of 5,371 women, 3247 (61%) were of normal weight, 1302 
(24%) were overweight, and 822 (15%) were obese entering their first pregnancy. Maternal 
characteristics associated with each BMI category are presented in Supplemental Table 1. 
  
Among women who were overweight or obese in their first pregnancy, 94% remained 
overweight or obese in their second pregnancy (Table 1). Mean gestation at booking visit did 
not differ between the first and second pregnancy for women included in the study (11.4 vs 
11.3 weeks; p=0.62).  
 
Inter-pregnancy BMI change followed an approximate normal distribution among women 
who were of normal weight, or overweight/obese in their first pregnancy (Figure 2). On 
average, women with a normal BMI gained 1kg/m2 between first and second pregnancies, 
while women who were overweight or obese gained 1.37kg/m2.  
 
A number of maternal characteristics and perinatal outcomes in the first pregnancy, were 
associated with changes in inter-pregnancy BMI (Table 2 and 3). Younger women, single 
women and women who were smokers were more likely to gain weight between pregnancies, 
while a diagnosis of gestational diabetes in the first pregnancy was protective against inter-
pregnancy weight gain (see tables 2 and 3). 
 
Among women with a normal BMI in their first pregnancy, a BMI increase of ≥4kg/m2 was 
associated with increased risk of developing GDM (aRR 1.97; 95% CI 1.22-3.19), a macrosomic 
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(aRR 4.06; 95% CI 2.25-7.34) or LGA infant (aRR 1.31 0.96-1.78) in the second pregnancy (Table 
4), while a reduction in BMI (≤-2kg/m2) was associated with an increased risk of SGA (aRR 
1.94; 1.19-3.16). Linear trends were observed between increasing BMI change and the 
prevalence of GDM or macrosomic infant in the second pregnancy.  
 
Among women who were overweight or obese in their first pregnancy, a BMI increase of ≥2 
to 4 and ≥4 kg/m2 was associated with increased risks of developing GDM in the second 
pregnancy (aRR 1.39; 95%CI 1.01-1.91 and aRR 1.64 95%CI 1.16-2.31; ptrend <0.001), while no 
associations were observed for a BMI increase and risk of a macrosomic, SGA, or LGA infant. 
In contrast, reduction in BMI (≤-2kg/m2) was associated with a reduced risk of GDM (aRR 0.58 
95% CI 0.37-0.90) and SGA (aRR 0.47; 95%CI 0.25-0.87). Linear trends were observed between 
increasing BMI change and the prevalence of GDM and SGA in the second pregnancy. 
Statistically significant interactions between maternal BMI category during the first pregnancy 
and inter-pregnancy BMI change was observed for the outcomes of SGA (p<0.001) and 




This study demonstrates that inter-pregnancy weight change affects women of a normal 
weight in their first pregnancy differently to women who are overweight/obese. Importantly, 
inter-pregnancy weight loss in women who are overweight/obese was associated with 
substantial reductions in the risk of developing gestational diabetes and small-for-gestational 
age babies, but not hypertensive disorders of pregnancy, macrosomia or large-for-gestational 
age babies. In contrast, inter-pregnancy weight gain in women of a normal weight was 
associated with an increased risk of gestational diabetes, large for gestational age and 
macrosomia in a subsequent pregnancy. Insulin resistance may be an underlying physiological 
pathway: as gestational diabetes and increased birthweight are all linked to increasing insulin 
resistance in pregnancy, independent of BMI, while an increased BMI is widely accepted to 
predispose to insulin resistance [25]. The only demonstrated effect of inter-pregnancy BMI 
change on preterm birth was an increased risk in women who were already overweight or 
obese and who gained between 2 and 4 units of BMI, but not in women who gained more 
than 4 kg/m2. No protective effect was seen with weight loss in this group.  
 
Our findings in relation to risk of gestational diabetes (in women of normal and increased 
BMI) support those of Villamor and Cnattingius, but in contrast to their study, we found no 
significant result in relation to hypertensive disorders of pregnancy [11].  
 
Another large study, performed by Bogearts et al [13] in Belgium 2009-11 showed an 
increased risk for macrosomia (aOR 1.42 (1.08-1.87)) with an inter-pregnancy weight gain of 
>2 kg/m2 in women who were overweight or obese in their first pregnancy. Our study included 
a larger proportion of overweight and obese women and our results were not significant for 
macrosomia, nor did we find a significantly increased risk of LGA in women with a BMI >25 
kg/m2.  
 
Borgearts et al. also showed that weight loss >1 kg/m2 in women with a BMI <25 increased 
the odds of low birthweight (aOR 2.22 (1.41-3.51)), while being protective for macrosomia 
(aOR 0.50 (0.35-0.71)). Our study demonstrated an increased risk of SGA with weight loss in 
this group, but did not confirm a protective effect for macrosomia.  
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The current study has a number of strengths compared to previous studies. Both Villamor and 
Bogearts analysed underweight and normal weight women together and used birthweight 
measures based on population data, not adjusted for maternal height, weight, and ethnicity.  
 
Until now, significant weight loss among women who are overweight or obese has mostly 
been studied in relation to risk of developing gestational diabetes and birthweight. Where 
previous landmark studies have only assessed BMI loss > 1 unit [11,13], we were able to assess 
higher degrees of BMI change. American studies have shown reducing risk of gestational 
diabetes with increasing degrees of weight loss, and a greater protective effect with a shift 
from obese to normal weight (aOR 0.21 (0.09-0.50) [14, 15]).  
 
Our findings in relation to birthweight may be compared with Jain et al. [17] and Gethun et 
al. [18], who studied birthweight in relation to inter-pregnancy BMI change between first and 
second pregnancies in Missouri, USA. Getahun et al. investigated BMI category shift between 
1989-97 and showed that in women who went from obese to normal-weight between 
pregnancies were less likely to have a large-for-gestational age baby in a subsequent 
pregnancy (aOR 1.5 (1.1-2.0)) than those who remained obese (aOR 2.3 (2.2-2.4)) when 
compared to women who maintained a normal BMI. An increased risk was seen in women 
who shifted from a normal to overweight BMI category (aOR 1.6 (1.5-1.7)), and that risk 
increased further with a shift to a higher category (aOR 2.0 (1.8-2.3) for women who went 
from normal weight to obese)[18].  Jain et al. presented BMI unit change in obese women 
exclusively between 1998 and 2005 and showed that while weight modulation affects the risk 
of large-for-gestational age, there was no significant effect on the risk of small-for-gestational 
age [17]. Our study shows a reduction in the incidence of SGA with weight loss in our 
overweight/obese cohort and showed an increased risk of macrosomia and large-for-
gestational age with weight gain in women of normal BMI in their first pregnancy. Like the 
Villamor and Bogearts studies, Jain et al. and Getahun et al. adjusted for only fetal sex and 
gestational age when determining whether a baby was appropriate size for dates, whereas 
we adjusted for maternal height, weight, ethnicity, and fetal sex and gestational age. 
Adjusting for maternal BMI may have removed some of the effect of inter-pregnancy weight 
change for birthweight outcomes.   
 
Excessive inter-pregnancy weight gain was demonstrated in young first-time mothers (also 
shown by Bogearts et al, [13] BMI change 1.10kg/m2 compared to 0.34-0.81kg/m2 (p< 0.001) 
in other age groups); smokers (also shown by Villamor and Cnattingius [11] BMI change 
0.99kg/m2 compared to 0.77kg/m2 in non smokers p <0.001) and single women (Table 2). It is 
also interesting to note that a diagnosis of GDM in a first pregnancy is protective for inter-
pregnancy weight gain, and may be at least partially secondary to the acknowledgement of a 
problem and subsequent healthy life style counseling offered to these women. 
 
Chen et al. [26] and Wallace et al. [27] each investigated the effect of inter-pregnancy weight 
change on preterm birth. Neither study demonstrated a statistically significant effect of inter-
pregnancy weight gain in the overweight/obese women on the incidence of preterm delivery. 
Wallace et al. investigated women in all BMI categories and found a non-statistically 
significant increase of 80% in spontaneous pre-term birth with weight loss of > 1 kg/m2 in 
women with a BMI of <25 kg/m2 in the index pregnancy, we were not able to confirm this 
finding.  
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Ours is a large study in a contemporary cohort studied over a 12-year period, allowing the 
analysis to measure, examine and adjust for inter-pregnancy interval amongst many other 
covariates. Given the retrospective nature of our study design, we were limited to utilising 
data that are routinely collected as part of clinical care and pregnancy outcomes reporting 
requirements.  As we investigated recurrent births occurring at a single tertiary hospital 
setting, there is a possibility that this group of women represents a higher risk group than that 
of the general population, which could impact the generalizability of our findings. Excluding 
women whose first antenatal visit was after 15 weeks gestation may have introduced 
selection bias. Since we did not have data on paternity or gestational weight gain we were 
unable to examine these potential effects or adjust for these confounders. As gestational 
weight gain is strongly associated with inter-pregnancy weight change, being unable to adjust 
for gestational weight gain makes it impossible to determine the impact of gestational weight 
gain in the first pregnancy separate to inter-pregnancy weight gain. One should exercise 
caution in interpreting the findings of our study in relation to preterm birth, as we have not 
separated iatrogenic preterm birth from spontaneous preterm birth.  
 
The public-health findings of our study are worthy of consideration. For example, if a woman 
1.6m tall, weighing 70kg in her first pregnancy (giving her an overweight BMI of 27) lost 6kg 
(2 BMI units), she would reduce her risk of developing GDM from 8.5% to  
4.9%, an absolute reduction of almost 50%. However, if she gained either 7kg (or 3 BMI units) 
or 12kg (or 5 BMI units) between pregnancies, she would increase her absolute risk to 11.8% 
or 13.9% respectively.  
 
While weight gain between pregnancies in Australian women is certainly the norm, inter-
pregnancy weight control represents an important target in all women to reduce the risk of 
adverse perinatal outcomes in a subsequent pregnancy. 
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Figure 1: Participant Flow Diagram 
 
 Singleton Births ≥20 weeks gestation 
Jan 2000 – Dec 2012 
N=55,466 
Matched First to Second Birth ≥20 weeks 
gestation 
N=8,368 




Underweight in first pregnancy (N=218) 
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BMI≥18.5 & <25 
Overweight 
BMI≥25 & <30 
Obese 
BMI>30 
Underweight 67 (2.1) 0 0 
Normal Weight 2575 (79.3) 127 (9.8) 3 (0.4) 
Overweight 558 (17.2) 807 (62.0) 73 (8.9) 
Obese 47 (1.5) 368 (28.3) 746 (90.8) 
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Table 2: Mean Change in Inter-pregnancy Body Mass Index 
According to Maternal Characteristics of the First Pregnancy  
Characteristic Normal Weight 












Total 3247 1.00   2124 1.42   
Maternal Age    <0.001    <0.001 
≤19 266 1.71 3.05  146 3.19 3.68  
20-24 759 1.38 2.40  499 1.61 3.23  
25-29 1177 0.80 1.78  758 1.26 3.03  
30-34 822 0.74 1.70  546 1.00 2.57  
≥35 223 0.63 1.76  175 0.81 2.88  
Ethnicity    <0.001    0.085 
Caucasian 2419 0.91 2.07  1852 1.35 3.09  
Aboriginal/TSI 57 2.04 3.62  46 2.14 3.32  
Asian 583 0.99 1.76  120 0.99 2.47  
Other 188 1.63 2.30  106 1.74 2.82  
Smoking Status    0.005    0.328 
Non-Smoker 2689 0.90 1.91  1622 1.39 2.87  
Quit During 
Pregnancy 
177 1.10 2.21  172 1.0 3.09  
Smoker 381 1.51 2.89  330 1.57 3.81  
Socioeconomic Status    0.010    0.081 
5 (Highest) 714 0.81 1.91  354 1.07 2.91  
4 733 0.93 1.94  473 1.46 2.64  
3 748 0.92 1.94  523 1.35 2.89  
2 507 0.99 2.24  373 1.19 3.42  
1 (Lowest) 545 1.35 2.42  401 1.72 3.42  
Breastfeeding Infant at 
Discharge from Hospital 
   0.014    0.034 
No 167 1.38 2.27  167 1.79 3.15  
Yes 3080 0.96 2.06  1957 1.32 3.04  
Married/Defacto    <0.001    <0.001 
No 664 1.39 2.67  438 2.46 3.61  
Yes 2576 0.88 1.88  1679 1.09 2.82  
# Totals may not sum due to missing data  
† Kruskal-Wallis tests 
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Table 3: Mean Change in Inter-pregnancy Body Mass Index 
According to Perinatal Outcomes of the First Pregnancy  
Characteristic Normal Weight 












Total 3247 1.00   2124 1.42   
Gestational 
Diabetes 
   0.476    <0.001 
No 3142 0.99 2.09  1988 1.43 3.05  




   <0.001    0.166 
No 3032 0.95 2.04  1824 1.35 3.04  
Yes 215 1.50 2.49  248 1.24 3.85  
Small-for-
Gestational Age 
   0.980    0.418 
No 2976 0.99 2.09  1876 1.39 2.93  
Yes 271 0.93 1.93  248 1.24 3.85  
Large-for-
Gestational Age 
   0.051    0.905 
No 2908 0.96 2.07  1875 1.37 3.08  
Yes 339 1.16 2.13  249 1.38 2.82  
Macrosomic Infant 
>4,500 kg 
   0.698    0.949 
No 3215 0.98 2.07  2087 1.37 3.06  
Yes 32 1.33 3.03  37 1.29 2.61  
Birth Method    0.222    0.620 
NVB 1831 0.96 2.05  977 1.44 2.99  
Assisted 736 0.93 2.02  461 1.39 3.01  
Em LSCS 589 1.15 2.26  592 1.35 2.99  
El LSCS 80 0.80 1.73  84 0.44 4.18  
Pregnancy Interval 
Time 
   <0.001    <0.001 
<1 806 0.86 2.00  548 1.15 2.43  
≥1 to <2  1316 0.70 1.85  770 1.09 2.94  
≥2 to <3 575 1.07 1.97  471 1.53 3.19  
≥3 550 1.73 2.56  335 2.14 3.80  
# Totals may not sum due to missing data  
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Table 4: Relative Risks for Adverse Perinatal Outcomes During the Second Pregnancy in Relation to Inter-
pregnancy Change in Body Mass Index Between the First and Second Pregnancy Stratified by Pre-
pregnancy Body Mass Index at First Pregnancy 
Outcome 
(cases) 
  Normal Weight 
(BMI≥18.5 & <25 kg/m2) 
Overweight/Obese 
(BMI≥25 kg/m2) 
 BMI Change 
(kg/m2) 
 n‡ %  Adjusted RR† 
(95% CI) 
n‡ % Adjusted RR† 
(95%CI) 
Gestational Diabetes ≤-2  5 3.9  1.11 (0.50-2.50) 14 7.1 0.58 (0.37-0.90) 
(n=342) -2 to 2  93 4.1  1.00 98 8.6 1.00 
 ≥2 to 4  27 4.7  1.36 (0.92-2.00) 45 10.3 1.39 (1.01-1.91) 
 ≥4  17 7.0  1.97 (1.22-3.19) 43 12.5 1.64 (1.16-2.31) 
 p, trend   0.051  0.008  0.011 <0.001 
Hypertensive Disorders of ≤-2  3 2.3  0.77 (0.28-2.14) 8 4.0 0.62 (0.30-1.26) 
Pregnancy -2 to 2  57 2.5  1.00 66 5.8 1.00 
(n=222) ≥2 to 4  15 2.6  0.98 (0.57-1.69) 36 8.2 1.22 (0.79-1.88) 
 ≥4  11 4.5  1.09 (0.55-2.16) 26 4.6 1.16 (0.70-1.93) 
 p, trend   0.234  0.887  0.072 0.372 
Macrosomic Infant  ≤-2  2 1.6  0.99 (0.23-4.33) 8 2.5 0.87 (0.34-2.23) 
(>4,500 kg) -2 to 2  35 1.5  1.00 34 3.0 1.00 
(n=128) ≥2 to 4  13 2.2  1.55 (0.83-2.87) 18 4.1 1.59 (0.88-2.88) 
 ≥4  13 5.4  4.06 (2.25-7.34) 8 2.3 0.87 (0.40-1.92) 
 p, trend   <0.001  <0.001  0.931 0.628 
Small-for-Gestational Age ≤-2  16 12.4  1.94 (1.19-3.16) 11 5.6 0.47 (0.25-0.87) 
(n=433) -2 to 2  153 6.7  1.00 104 9.1 1.00 
 ≥2 to 4  36 6.2  0.88 (0.62-1.24) 49 11.2 1.21 (0.87-1.67) 
 ≥4  24 9.9  1.44 (0.96-2.16) 40 11.6 1.04 (0.73-1.47) 
 p, trend   0.848  0.825  0.015 0.023 
Large-for-Gestational Age ≤-2  16 12.4  1.16 (0.73-1.82) 29 14.7 1.18 (0.80-1.73) 
(n=664) -2 to 2  263 11.5  1.00 148 12.9 1.00 
 ≥2 to 4  69 11.9  1.07 (0.84-1.36) 65 14.8 1.20 (0.92-1.57) 
 ≥4  35 14.4  1.31 (0.96-1.78) 39 11.3 0.97 (0.69-1.35) 
 p, trend   0.308  0.233  0.518 0.873 
Preterm Birth ≤-2  7 5.4  1.23 (0.60-2.52) 14 7.1 1.40 (0.76-2.57) 
(n=259) -2 to 2  102 4.5  1.00 54 4.7 1.00 
 ≥2 to 4  27 4.7  1.00 (0.66-1.52) 34 7.8 1.59 (1.05-2.41) 
 ≥4  7 2.9  0.53 (0.24-1.17) 14 4.1 0.90 (0.53-1.54) 
 p, trend   0.343  0.146  0.768 0.982 
‡ Number of cases with outcome of interest †Adjusted for maternal age, socioeconomic status, maternal 
BMI in first pregnancy, smoking status, race, inter-pregnancy interval time, and first pregnancy outcomes 
(including gestational diabetes, pregnancy induced hypertensive disorders, birth method, LGA/SGA 
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Supplemental Table 1: Maternal Characteristics According to Body Mass Index 
Category in First Pregnancy 
Characteristic Normal Weight 
BMI≥18.5 & <25 
Overweight/Obese 
BMI≥25  
Total N=3,247 N=2,124 
Maternal Age, years, N (%)   
≤19 266 (8.2) 146 (6.9) 
20-24 759 (23.4) 499 (23.5) 
25-29 1177 (36.3) 758 (35.7) 
30-34 822 (25.3) 546 (25.7) 
≥35 223 (6.9) 175 (8.2) 
Ethnicity, N (%)   
Caucasian 2419 (74.5) 1852 (87.2) 
Aboriginal/TSI 57 (1.8) 46 (2.2) 
Asian 583 (18.0) 120 (5.7) 
Other 188 (5.8) 106 (5.0) 
Smoking Status, N (%)   
Non-Smoker 2689 (82.8) 1622 (76.4) 
Quit During Pregnancy 177 (5.5) 172 (8.1) 
Smoker 381 (11.7) 330 (15.5) 
Socioeconomic Status, N (%)   
5 (Highest) 714 (22.0) 354 (16.7) 
4 733 (22.6) 473 (22.3) 
3 748 (23.0) 523 (24.6) 
2 507 (15.6) 373 (17.6) 
1 (Lowest) 545 (16.8) 401 (18.9) 
Pre-Existing Diabetes, N (%) 7 (0.2) 24 (1.1) 
Pre-Existing Hypertension, N (%) 16 (0.9) 34 (1.6) 
Breastfeeding Infant at Discharge 
from Hospital, N (%) 
3080 (94.9) 1957 (92.1) 
Married/Defacto, N (%) 2576 (79.5) 1679 (79.3) 
Gestational Diabetes, N (%) 105 (3.2) 136 (6.4) 
Hypertensive Disorders of 
Pregnancy, N (%) 
215 (6.6) 300 (14.1) 
Small-for-Gestational Age, N (%) 271 (8.4) 248 (11.7) 
Large-for-Gestational Age, N (%) 339 (10.4) 249 (11.7) 
Macrosomic Infant >4,500 kg, N (%) 32 (1.0) 37 (1.7) 
Birth Method, N (%)   
NVB 1831 (56.6) 977 (45.8) 
Assisted Vaginal Delivery 736 (22.7) 461 (21.7) 
LSCS 669 (20.6) 676 (31.8) 
Interpregnancy BMI Change, mean 
(SD) 
0.98 (2.08) 1.37 (3.05) 
Pregnancy Interval Time, Years, N 
(%) 
  
<1 806 (24.8) 548 (25.8) 
≥1 to <2  1316 (40.5) 770 (36.3) 
≥2 to <3 575 (17.7) 471 (22.2) 
≥3 550 (16.9) 335 (15.8) 
Abbreviations: BMI, body mass index; NVB, normal vaginal birth; LSCS, lower segment caesarean section  
 
 
